Ratings
0
Nobody has rated this yet. Be the first!
Works
6
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years
Systemic Inflammation, COPD, and Pulmonary Hypertension
Abstracts from the 8th International Conference on cGMP Generators, Effectors and Therapeutic Implications : Bamberg, Germany. 23-25 June, 2017
Long-term therapy with inhaled iloprost in patients with pulmonary hypertension.
REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat.
Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study.
